Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of Histology and Tumor Grade on Clinical Outcomes Beyond 5 Years of Follow-Up in a Large Cohort of Renal Cell Carcinomas

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.07.003Source: DataRank Database

Impact of Histology and Tumor Grade on Clinical Outcomes Beyond 5 Years of Follow-Up in a Large Cohort of Renal Cell Carcinomas is a research paper published in Clinical Genitourinary Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.39)OA: greenTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Maria Luana Poeta ORCID,Ruth M. Pfeiffer ORCID,Dana Hashim,Catherine L. Callahan ORCID,Steno Sentinelli

Live enrichment

PubMed:34362694 PMC:PMC8490324 OpenAlex:https://openalex.org/W3182152656

Intramural NIH HHS

Grant: ZIA CP101231

National Institutes of Health

Division of Cancer Epidemiology and Genetics, National Cancer Institute

National Cancer Institute

FWCI

0.39

Citation Percentile

0.6%

Citation Trend

2023

2024

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8490324

publisherhttps://api.elsevier.com/content/article/PII:S1558767321001312?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1558767321001312?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.clgc.2021.07.003

Fields of Study

Renal cell carcinoma treatmentMultiple and Secondary Primary CancersBiological Research and Disease StudiesCarcinoma, Renal CellCohort StudiesFollow-Up StudiesHumansKidney NeoplasmsNeoplasm Recurrence, Local

MeSH Terms

Carcinoma, Renal CellFollow-Up StudiesHumansKidney NeoplasmsNeoplasm Recurrence, LocalCohort Studies

Keywords

MedicineHistologyCohortRenal cell carcinomaClear cellOncologyPathologyInternal medicineSurveillanceRecurrenceAbsolute Risk

Sustainable Development Goals

SDG 0: Good health and well-being

Impact of Histology and Tumor Grade on Clinical Outcomes Beyond 5 Years of Follow-Up in a Large Cohort of Renal Cell Carcinomas

FAIR Checklist

Authors (15)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)